Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928862 · ClinicalTrials.gov registry record · Phase 1
Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy
A Phase 1 study of Need for Bowel Preparation, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 78
- Enrollment target
- 9
- Study locations
NCT01928862 is a Phase 1 study of Need for Bowel Preparation that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 78 participants. The trial reports 9 study locations across 8 states.
The verdict
NCT01928862, a Phase 1 study of Need for Bowel Preparation, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 78 participants
- Enrollment target
- 9
- Study locations
Study Summary
To study the efficacy and safety of Prepopik® in children aged 9 to 16 years for overall colon cleansing in preparation of colonoscopy
Conditions Studied
Interventions
- DRUG Prepopik® ½ Sachet x 2 (9-12 years)
- DRUG Prepopik® 1 Sachet x 2 (9-12 years)
- DRUG Oral polyethylene glycol (PEG) based preparation (9-12 years)
- DRUG Prepopik® 1 Sachet x 2 (13-16 years)
- DRUG Oral polyethylene glycol (PEG) based preparation (13-16 years)
Study Locations (9)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- Children's Hospital of Pittsburgh - Pittsburgh
Alabama
- University of Alabama - Birmingham
California
- University California San Diego - Rady's Children's Hospital - San Diego
Indiana
- IU Medical Center / Riley Hospital - Indianapolis
Maryland
- John Hopkins - Baltimore
New York
- Stony Brook Children's - Stony Brook
Ohio
- Nationwide Children's Hospital - Columbus
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2014-06-03 |
| Est. Completion | 2017-03-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01928862
The ClinicalTrials.gov registry entry for NCT01928862 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Need for Bowel Preparation appearing as the primary indexed condition, and to 5 interventions - of which Prepopik® ½ Sachet x 2 (9-12 years) is the first listed.
NCT01928862 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Pennsylvania, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT01928862 about?
NCT01928862 is a clinical study titled "Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy". To study the efficacy and safety of Prepopik® in children aged 9 to 16 years for overall colon cleansing in preparation of colonoscopy
What is the current status of trial NCT01928862?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 78 participants. The study started on 2014-06-03. Estimated completion is 2017-03-16.
What conditions does trial NCT01928862 study?
This clinical trial studies the following conditions: Need for Bowel Preparation.
What interventions are being tested in trial NCT01928862?
The interventions under investigation include: Prepopik® ½ Sachet x 2 (9-12 years) (DRUG), Prepopik® 1 Sachet x 2 (9-12 years) (DRUG), Oral polyethylene glycol (PEG) based preparation (9-12 years) (DRUG), Prepopik® 1 Sachet x 2 (13-16 years) (DRUG), Oral polyethylene glycol (PEG) based preparation (13-16 years) (DRUG).
Who is sponsoring clinical trial NCT01928862?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01928862 being conducted?
This trial has 9 study locations across Alabama, California, Indiana, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.